Ghost Tree Capital »

IsoRay shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of IsoRay (CATX) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in IsoRay

Tip: Access up to 7 years of quarterly data

All positions including IsoRay held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in IsoRay by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.1M 6.0M 1.19
2023-12-31 $643k 1.6M 0.40

More positions owned by Ghost Tree Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Axsome Therapeutics (AXSM)
Sarepta Therapeutics (SRPT)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Roivant Sciences SHS (ROIV)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Miragen Therapeutics (VRDN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Alnylam Pharmaceuticals (ALNY)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Savara (SVRA)

View all positions for Ghost Tree Capital

Top funds holding IsoRay

Deerfield Management Company
Commodore Capital
Marshall Wace
Vanguard Group
Octagon Capital Advisors
Point72 Asset Management
Henderson Group
Sphera Funds Management
Citadel Advisors
Hills Bank And Trust Company
Laurion Capital Management
Silverarc Capital Management
BlackRock
OrbiMed Advisors
Ghost Tree Capital

View all funds holding IsoRay